BIIB PEER ANALYSIS

Biogen Inc — metric-by-metric comparison with peers and the industry median

BIIBBiogen Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

BIIBIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	BIIB	AZN	BAYN	SAN	GRF	AZN	Ind. Median
P/E	23.37	29.05	—	8.81●	14.78	28.79	23.37
P/B	1.72	6.38	1.82	1.25	1.12●	6.36	4.60
EV/EBITDA	12.71	16.08	24.14	9.72●	10.50	15.93	13.81
P/S	3.25	4.99	1.16	1.97	0.83●	4.95	3.25

Financial Health
Metric	BIIB	AZN	BAYN	SAN	GRF	AZN	Ind. Median
Current Ratio	3.06●	0.91	1.06	1.01	2.47	0.91	1.25
Debt/Equity	35.2%	71.7%	134.8%	27.5%●	177.2%	71.7%	94.3%
NetDebt/EBITDA	0.84●	1.29	9.19	1.33	6.22	1.28	1.35

Profitability
Metric	BIIB	AZN	BAYN	SAN	GRF	AZN	Ind. Median
Net Margin	13.9%	17.2%	-4.8%	22.3%●	5.6%	17.2%	15.0%
ROE	7.7%	23.5%	-7.0%	14.1%	7.5%	23.7%●	23.7%
ROA	4.8%	9.4%	-2.0%	8.0%	2.0%	9.5%●	8.0%
EBITDA Margin	27.4%	33.7%	7.7%	23.4%	19.3%	33.8%●	28.4%

Growth + Dividend
Metric	BIIB	AZN	BAYN	SAN	GRF	AZN	Ind. Median
Rev. Growth	0.4%	9.9%●	-2.9%	3.3%	0.9%	9.7%	3.3%
NI Growth	-7.2%	33.7%	—	59.8%	112.7%●	32.9%	32.9%
Div. Yield	—	0.2%	0.2%	0.0%	2.1%	2.2%●	2.1%
Payout	—	47.3%	-5.9%	0.0%	30.8%	47.0%	45.7%

Valuation
Metric	BIIB	BMY	PFE	GILD	AMGN	OGN	Ind. Median
P/E	23.37	16.33	18.61	17.86	26.09	14.48●	23.37
P/B	1.72	5.92	1.55●	7.00	22.15	3.94	4.60
EV/EBITDA	12.71	11.11	11.39	12.22	14.91	7.96●	13.81
P/S	3.25	2.45	2.20	5.54	5.47	0.58●	3.25

Financial Health
Metric	BIIB	BMY	PFE	GILD	AMGN	OGN	Ind. Median
Current Ratio	3.06●	1.42	1.25	1.97	1.26	1.97	1.25
Debt/Equity	35.2%●	221.5%	71.5%	94.3%	623.8%	948.9%	94.3%
NetDebt/EBITDA	0.84●	2.47	3.07	0.85	2.71	5.39	1.35

Profitability
Metric	BIIB	BMY	PFE	GILD	AMGN	OGN	Ind. Median
Net Margin	13.9%	15.0%	11.8%	31.0%●	20.9%	4.0%	15.0%
ROE	7.7%	38.8%	8.3%	43.2%	101.3%●	34.0%	23.7%
ROA	4.8%	8.1%	3.6%	16.4%●	8.6%	1.9%	8.0%
EBITDA Margin	27.4%	28.4%	26.5%	48.7%●	44.8%	22.4%	28.4%

Growth + Dividend
Metric	BIIB	BMY	PFE	GILD	AMGN	OGN	Ind. Median
Rev. Growth	0.4%	1.8%	1.4%	3.5%	9.1%●	-2.1%	3.3%
NI Growth	-7.2%	34.2%	-4.8%	54.5%●	31.5%	-67.2%	32.9%
Div. Yield	—	4.5%	7.2%●	2.5%	2.7%	0.6%	2.1%
Payout	—	69.7%	130.5%	43.8%	66.7%	8.9%	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BIIB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.